Document is current
Any future updates will be listed below
-
Authors
Kowarik, Michael https://orcid.org/0000-0002-6512-9855
Wetter, Michael
Haeuptle, Micha A.
Braun, Martin
Steffen, Michael
Kemmler, Stefan
Ravenscroft, Neil
De Benedetto, Gianluigi
Zuppiger, Matthias
Sirena, Dominique
Cescutti, Paola
Wacker, Michael
-
Funding
Funding for this research was provided by:
GlycoVaxyn AG
LimmaTech Biologics AG
- License Information
-
More Information
Article History
Received: 28 December 2020
Revised: 18 February 2021
Accepted: 24 February 2021
First Online: 17 March 2021
Declarations
:
: Employees of LimmaTech Biologics AG are receiving salary from their employer and may own shares of the company. The bioconjugation technology is owned by GlaxoSmithKline Biologicals SA and is protected by several patents.
: Not applicable.
: Not applicable.
: All authors have consented to publish this material.
